Paola Neri

Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

Laurence Catley, Ellen Weisberg, Tanyel Kiziltepe et al. · Blood · 2006 · 340 citations · Full text

Medicine, Oncology, Pharmacology +17

The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients

Mirco Friedrich, Paola Neri, Niklas Kehl et al. · Cancer Cell · 2023 · 247 citations · Full text

Life Sciences, Immunology, Oncology +17

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications

Masood A. Shammas, Paola Neri, Hemanta Koley et al. · Blood · 2006 · 165 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

A Novel Carbohydrate-Based Therapeutic GCS-100 Overcomes Bortezomib Resistance and Enhances Dexamethasone-Induced Apoptosis in Multiple Myeloma Cells

Dharminder Chauhan, Guilan Li, Klaus Podar et al. · Cancer Research · 2005 · 162 citations · Full text

Medicine, Oncology, Pharmacology +17

Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells

Pierfrancesco Tassone, Victor S. Goldmacher, Paola Neri et al. · Blood · 2004 · 124 citations · Full text

Medicine, Immunology, Oncology +9